B-intervention	0	13	Mediterranean
I-intervention	14	18	Diet
O	19	22	and
O	23	31	Invasive
O	32	38	Breast
O	39	45	Cancer
O	46	50	Risk
O	51	56	Among
O	57	62	Women
O	63	65	at
O	66	70	High
O	71	85	Cardiovascular
O	86	90	Risk
O	91	93	in
O	94	97	the
O	98	106	PREDIMED
O	107	112	Trial
O	112	113	:
O	114	115	A
O	116	126	Randomized
O	127	135	Clinical
O	136	141	Trial
O	141	142	.

O	143	149	Breast
O	150	156	cancer
O	157	159	is
O	160	163	the
O	164	171	leading
O	172	177	cause
O	178	180	of
O	181	187	female
O	188	194	cancer
O	195	201	burden
O	201	202	,
O	203	206	and
O	207	210	its
O	211	220	incidence
O	221	224	has
O	225	234	increased
O	235	237	by
O	238	242	more
O	243	247	than
O	248	250	20
O	250	251	%
O	252	261	worldwide
O	262	267	since
O	268	272	2008
O	272	273	.

O	274	278	Some
O	279	292	observational
O	293	300	studies
O	301	305	have
O	306	315	suggested
O	316	320	that
O	321	324	the
O	325	338	Mediterranean
O	339	343	diet
O	344	347	may
O	348	354	reduce
O	355	358	the
O	359	363	risk
O	364	366	of
O	367	373	breast
O	374	380	cancer
O	380	381	.

O	382	384	To
O	385	393	evaluate
O	394	397	the
O	398	404	effect
O	405	407	of
O	408	409	2
O	410	423	interventions
O	424	428	with
O	429	442	Mediterranean
O	443	447	diet
O	448	450	vs
O	451	454	the
B-control	455	461	advice
I-control	462	464	to
I-control	465	471	follow
I-control	472	473	a
I-control	474	477	low
I-control	477	478	-
I-control	478	481	fat
I-control	482	486	diet
I-control	487	488	(
I-control	488	495	control
I-control	495	496	)
O	497	499	on
O	500	506	breast
O	507	513	cancer
O	514	523	incidence
O	523	524	.

O	525	528	The
O	529	537	PREDIMED
O	538	543	study
O	544	546	is
O	547	548	a
O	549	550	1
O	550	551	:
O	551	552	1
O	552	553	:
O	553	554	1
O	555	565	randomized
O	565	566	,
O	567	573	single
O	573	574	-
O	574	579	blind
O	579	580	,
O	581	591	controlled
O	592	597	field
O	598	603	trial
O	604	613	conducted
O	614	616	at
O	617	624	primary
O	625	631	health
O	632	636	care
O	637	644	centers
O	645	647	in
B-location	648	653	Spain
O	653	654	.

O	655	659	From
O	660	664	2003
O	665	667	to
O	668	672	2009
O	672	673	,
B-total-participants	674	678	4282
O	679	684	women
O	685	689	aged
B-age	690	692	60
I-age	693	695	to
I-age	696	698	80
I-age	699	704	years
O	705	708	and
B-eligibility	709	711	at
I-eligibility	712	716	high
I-eligibility	717	731	cardiovascular
I-eligibility	732	739	disease
I-eligibility	740	744	risk
O	745	749	were
O	750	759	recruited
O	760	765	after
O	766	776	invitation
O	777	779	by
O	780	785	their
O	786	793	primary
O	794	798	care
O	799	809	physicians
O	809	810	.

O	811	823	Participants
O	824	828	were
O	829	837	randomly
O	838	847	allocated
O	848	850	to
O	851	852	a
O	853	866	Mediterranean
O	867	871	diet
O	872	884	supplemented
O	885	889	with
O	890	895	extra
O	895	896	-
O	896	902	virgin
O	903	908	olive
O	909	912	oil
O	912	913	,
O	914	915	a
O	916	929	Mediterranean
O	930	934	diet
O	935	947	supplemented
O	948	952	with
O	953	958	mixed
O	959	963	nuts
O	963	964	,
O	965	967	or
O	968	969	a
O	970	977	control
O	978	982	diet
O	983	984	(
O	984	990	advice
O	991	993	to
O	994	1000	reduce
O	1001	1008	dietary
O	1009	1012	fat
O	1012	1013	)
O	1013	1014	.

O	1015	1021	Breast
O	1022	1028	cancer
O	1029	1038	incidence
O	1039	1042	was
O	1043	1044	a
O	1045	1057	prespecified
O	1058	1067	secondary
O	1068	1075	outcome
O	1076	1078	of
O	1079	1082	the
O	1083	1088	trial
O	1089	1092	for
O	1093	1098	women
O	1099	1106	without
O	1107	1108	a
O	1109	1114	prior
O	1115	1122	history
O	1123	1125	of
O	1126	1132	breast
O	1133	1139	cancer
O	1140	1141	(
O	1141	1142	n
O	1143	1144	=
B-total-participants	1145	1149	4152
O	1149	1150	)
O	1150	1151	.

O	1152	1157	After
O	1158	1159	a
O	1160	1166	median
O	1167	1173	follow
O	1173	1174	-
O	1174	1176	up
O	1177	1179	of
O	1180	1181	4
O	1181	1182	.
O	1182	1183	8
O	1184	1189	years
O	1189	1190	,
O	1191	1193	we
O	1194	1204	identified
O	1205	1207	35
O	1208	1217	confirmed
B-outcome	1218	1226	incident
I-outcome	1227	1232	cases
I-outcome	1233	1235	of
I-outcome	1236	1242	breast
I-outcome	1243	1249	cancer
O	1249	1250	.

O	1251	1259	Observed
O	1260	1265	rates
O	1266	1267	(
O	1267	1270	per
O	1271	1275	1000
O	1276	1282	person
O	1282	1283	-
O	1283	1288	years
O	1288	1289	)
O	1290	1294	were
O	1295	1296	1
O	1296	1297	.
O	1297	1298	1
O	1299	1302	for
O	1303	1306	the
O	1307	1320	Mediterranean
O	1321	1325	diet
O	1326	1330	with
O	1331	1336	extra
O	1336	1337	-
O	1337	1343	virgin
O	1344	1349	olive
O	1350	1353	oil
O	1354	1359	group
O	1359	1360	,
O	1361	1362	1
O	1362	1363	.
O	1363	1364	8
O	1365	1368	for
O	1369	1372	the
O	1373	1386	Mediterranean
O	1387	1391	diet
O	1392	1396	with
O	1397	1401	nuts
O	1402	1407	group
O	1407	1408	,
O	1409	1412	and
O	1413	1414	2
O	1414	1415	.
O	1415	1416	9
O	1417	1420	for
O	1421	1424	the
O	1425	1432	control
O	1433	1438	group
O	1438	1439	.

O	1440	1443	The
B-outcome	1444	1457	multivariable
I-outcome	1457	1458	-
I-outcome	1458	1466	adjusted
I-outcome	1467	1473	hazard
I-outcome	1474	1480	ratios
O	1481	1483	vs
O	1484	1487	the
O	1488	1495	control
O	1496	1501	group
O	1502	1506	were
O	1507	1508	0
O	1508	1509	.
O	1509	1511	32
O	1512	1513	(
O	1513	1515	95
O	1515	1516	%
O	1517	1519	CI
O	1519	1520	,
O	1521	1522	0
O	1522	1523	.
O	1523	1525	13
O	1525	1526	-
O	1526	1527	0
O	1527	1528	.
O	1528	1530	79
O	1530	1531	)
O	1532	1535	for
O	1536	1539	the
O	1540	1553	Mediterranean
O	1554	1558	diet
O	1559	1563	with
O	1564	1569	extra
O	1569	1570	-
O	1570	1576	virgin
O	1577	1582	olive
O	1583	1586	oil
O	1587	1592	group
O	1593	1596	and
O	1597	1598	0
O	1598	1599	.
O	1599	1601	59
O	1602	1603	(
O	1603	1605	95
O	1605	1606	%
O	1607	1609	CI
O	1609	1610	,
O	1611	1612	0
O	1612	1613	.
O	1613	1615	26
O	1615	1616	-
O	1616	1617	1
O	1617	1618	.
O	1618	1620	35
O	1620	1621	)
O	1622	1625	for
O	1626	1629	the
O	1630	1643	Mediterranean
O	1644	1648	diet
O	1649	1653	with
O	1654	1658	nuts
O	1659	1664	group
O	1664	1665	.

O	1666	1668	In
O	1669	1677	analyses
O	1678	1682	with
B-outcome	1683	1689	yearly
I-outcome	1690	1700	cumulative
I-outcome	1701	1708	updated
I-outcome	1709	1716	dietary
I-outcome	1717	1726	exposures
O	1726	1727	,
O	1728	1731	the
O	1732	1738	hazard
O	1739	1744	ratio
O	1745	1748	for
O	1749	1753	each
O	1754	1764	additional
O	1765	1766	5
O	1766	1767	%
O	1768	1770	of
O	1771	1779	calories
O	1780	1784	from
O	1785	1790	extra
O	1790	1791	-
O	1791	1797	virgin
O	1798	1803	olive
O	1804	1807	oil
O	1808	1811	was
O	1812	1813	0
O	1813	1814	.
O	1814	1816	72
O	1817	1818	(
O	1818	1820	95
O	1820	1821	%
O	1822	1824	CI
O	1824	1825	,
O	1826	1827	0
O	1827	1828	.
O	1828	1830	57
O	1830	1831	-
O	1831	1832	0
O	1832	1833	.
O	1833	1835	90
O	1835	1836	)
O	1836	1837	.

O	1838	1842	This
O	1843	1845	is
O	1846	1849	the
O	1850	1855	first
O	1856	1866	randomized
O	1867	1872	trial
O	1873	1880	finding
O	1881	1883	an
O	1884	1890	effect
O	1891	1893	of
O	1894	1895	a
O	1896	1900	long
O	1900	1901	-
O	1901	1905	term
O	1906	1913	dietary
O	1914	1926	intervention
O	1927	1929	on
O	1930	1936	breast
O	1937	1943	cancer
O	1944	1953	incidence
O	1953	1954	.

O	1955	1958	Our
O	1959	1966	results
O	1967	1974	suggest
O	1975	1976	a
O	1977	1987	beneficial
O	1988	1994	effect
O	1995	1997	of
O	1998	1999	a
O	2000	2013	Mediterranean
O	2014	2018	diet
O	2019	2031	supplemented
O	2032	2036	with
O	2037	2042	extra
O	2042	2043	-
O	2043	2049	virgin
O	2050	2055	olive
O	2056	2059	oil
O	2060	2062	in
O	2063	2066	the
O	2067	2074	primary
O	2075	2085	prevention
O	2086	2088	of
O	2089	2095	breast
O	2096	2102	cancer
O	2102	2103	.

O	2104	2109	These
O	2110	2117	results
O	2118	2122	come
O	2123	2127	from
O	2128	2129	a
O	2130	2139	secondary
O	2140	2148	analysis
O	2149	2151	of
O	2152	2153	a
O	2154	2162	previous
O	2163	2168	trial
O	2169	2172	and
O	2173	2176	are
O	2177	2182	based
O	2183	2185	on
O	2186	2189	few
O	2190	2198	incident
O	2199	2204	cases
O	2205	2208	and
O	2208	2209	,
O	2210	2219	therefore
O	2219	2220	,
O	2221	2225	need
O	2226	2228	to
O	2229	2231	be
O	2232	2241	confirmed
O	2242	2244	in
O	2245	2251	longer
O	2251	2252	-
O	2252	2256	term
O	2257	2260	and
O	2261	2267	larger
O	2268	2275	studies
O	2275	2276	.

O	2277	2283	ISRCTN
O	2283	2284	.
O	2284	2287	org
O	2288	2298	Identifier
O	2298	2299	:
O	2300	2314	ISRCTN35739639
O	2314	2315	.
